epcore cll-1: ensayo fase iii de epcoritamab en llc r/r
Published 2 years ago • 21 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
3:48
resultados del estudio de fase i/ii de epcoritamab r-dhax/c en pacientes con ldcbg r/r
-
7:19
ifcc clinical case 2:malaysia lee bee sun
-
12:15
retos al seleccionar terapia de primera línea en llc
-
1:06
agentes/co2 paso 1: preparacion
-
2:36
ensayos elevate cll tn & ascend en llc
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
3:56
transcend-cll-004 liso-cel en llc
-
1:11
epcoritamab combined with gemox in b-nhl: updated results from epcore nhl-2
-
1:06
crelio lims software review - by jaime arriola (nexus solutions usa)
-
3:21
yhlo iflash 1800 chemiluminescence immunoassay analyzer
-
2:13
resistance mechanisms in cll and the importance of genomic re-testing
-
2:32
ifcg for first-line treatment of ighv-mutated cll
-
1:31
using genomics to better understand the pathogenesis of cll & for early disease diagnosis
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
1:04
a phase i/ii study evaluating ms-553 in patients with cll/sll
-
2:18
first-line ibrutinib and venetoclax in cll
-
2:12
complete epigenome of cll reveals important areas of dysregulation